Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Diabetes Science and Technology is Scopus-indexed (Q1, CiteScore 9.3), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 1932-2968Verify ISSN ↗
Publisher: SAGE Publications Inc.
Cost to publish: About US$3,900 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 33 / 250 | 87th | Q1 |
| Internal Medicine | 26 / 179 | 85th | Q1 |
| Biomedical Engineering | 71 / 342 | 79th | Q1 |
| Bioengineering | 39 / 168 | 77th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2007–present, best quartile Q1, CiteScore 9.3.
Journal of Diabetes Science and Technology is Q1 in Endocrinology, Diabetes and Metabolism (rank 33 of 250), Q1 in Internal Medicine (rank 26 of 179) and Q1 in Biomedical Engineering (rank 71 of 342), by CiteScore 2025. It is ranked in 4 subject areas in all.
Journal of Diabetes Science and Technology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.3, which places it in quartile Q1 at the 87th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.256, quartile Q1, with an H-index of 106.
The publisher lists an article processing charge of about US$3,900 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Diabetes Science and Technology is published by SAGE Publications Inc. Its ISSN is 1932-2968.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Diabetes Science and Technology has an h-index of 124 and a 2-year mean of 4.36 citations per paper (OpenAlex). Its Scopus CiteScore is 9.3, quartile Q1. On 2-year citations it ranks #46 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Journal of Diabetes Science and Technology published 210 papers in 2025; its busiest recent year was 2021 with 259. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 76 research articles (2026), authors are most often from United States (37.3%), China (8.9%) and Denmark (7.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.